MedTrace Logo

Back Pain in Patients With Severe Osteoporosis

NCT00761332 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2011-06-21

No results posted yet for this study

Summary

The purpose of this study is to compare the effectiveness of teriparatide versus therapies that decrease bone loss to prevent new or worsening back pain in patients with osteoporosis seen in clinical practice.

Conditions

Interventions

DRUG

teriparatide

treatment will be prescribed according to usual standard of care

DRUG

antiresorptives

treatment will be prescribed according to usual standard of care

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Hong Kong
  • India
  • Malaysia
  • Mexico
  • Pakistan
  • Singapore
  • South Korea
  • Taiwan
  • Thailand

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00761332 on ClinicalTrials.gov